Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Curevac N.V. (CVAC)

Curevac N.V. (CVAC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,574,785
  • Shares Outstanding, K 187,121
  • Annual Sales, $ 115,580 K
  • Annual Income, $ -462,030 K
  • 60-Month Beta 2.96
  • Price/Sales 22.18
  • Price/Cash Flow N/A
  • Price/Book 3.38
Trade CVAC with:

Options Overview Details

View History
  • Implied Volatility 82.36% ( -1.14%)
  • Historical Volatility 57.39%
  • IV Percentile 39%
  • IV Rank 30.61%
  • IV High 125.01% on 07/01/22
  • IV Low 63.55% on 03/18/22
  • Put/Call Vol Ratio 1.50
  • Today's Volume 15
  • Volume Avg (30-Day) 217
  • Put/Call OI Ratio 1.43
  • Today's Open Interest 17,914
  • Open Int (30-Day) 20,708

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.58
  • Number of Estimates 1
  • High Estimate -0.58
  • Low Estimate -0.58
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.06%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.39 +11.06%
on 07/15/22
15.62 -11.91%
on 07/06/22
-0.33 (-2.34%)
since 07/05/22
3-Month
12.39 +11.06%
on 07/15/22
20.06 -31.41%
on 05/20/22
-2.86 (-17.21%)
since 05/05/22
52-Week
12.39 +11.06%
on 07/15/22
75.68 -81.82%
on 08/26/21
-48.77 (-77.99%)
since 08/05/21

Most Recent Stories

More News
Wall Street Analysts Predict a 96% Upside in CureVac N.V. (CVAC): Here's What You Should Know

The mean of analysts' price targets for CureVac N.V. (CVAC) points to a 96.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts...

CVAC : 13.76 (+0.44%)
CureVac Files Patent Infringement Lawsuit in Germany Against BioNTech

TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / July 5, 2022 / CureVac N.V. (NASDAQ:CVAC), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic...

CVAC : 13.76 (+0.44%)
CureVac Announces Voting Results of General Meeting

TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / June 22, 2022 / CureVac N.V. (Nasdaq:CVAC), a global clinical-stage biopharmaceutical company developing a new class of transformative medicines based on...

CVAC : 13.76 (+0.44%)
CureVac Accelerates Oncology Strategy with Acquisition of Frame Cancer Therapeutics, Adding Novel Antigen Discovery Platform

TÜBINGEN, GERMANY and AMSTERDAM, NETHERLANDS / ACCESSWIRE / June 8, 2022 / CureVac N.V. (NASDAQ:CVAC), a global biopharmaceutical company developing a new class of transformative medicines based on messenger...

CVAC : 13.76 (+0.44%)
CureVac Announces Changes of CDO - Myriam Mendila to Succeed Klaus Edvardsen

TÜBINGEN, DEUTSCHLAND and BOSTON, MA / ACCESSWIRE / June 8, 2022 / CureVac N.V. (NASDAQ:CVAC), a global biopharmaceutical company developing a new class of transformative medicines based on messenger...

CVAC : 13.76 (+0.44%)
Wall Street Analysts See a 53% Upside in CureVac N.V. (CVAC): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of 53.3% in CureVac N.V. (CVAC). While the effectiveness of this highly sought-after metric is questionable, the positive...

CVAC : 13.76 (+0.44%)
CureVac Partners with myNEO to Identify Novel Antigen Targets for mRNA-Based Cancer Vaccine Development

TÜBINGEN, GERMANY and GHENT, BELGIUM / ACCESSWIRE / May 25, 2022 / CureVac N.V. (Nasdaq:CVAC), a global biopharmaceutical company developing a new class of transformative medicines based on messenger...

CVAC : 13.76 (+0.44%)
Curevac Announces Financial Results For The First Quarter Of 2022 And Provides Business Update

TÜBINGEN, GERMANY and BOSTON MA / ACCESSWIRE / May 25, 2022 / CureVac N.V. (Nasdaq:CVAC), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic...

CVAC : 13.76 (+0.44%)
CureVac (CVAC) Q1 2022 Earnings Call Transcript

CVAC earnings call for the period ending March 31, 2022.

CVAC : 13.76 (+0.44%)
CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2021 and Provides Business Update

Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.

CVAC : 13.76 (+0.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

CureVac B.V. is a clinical-stage biopharmaceutical company. It engages in developing medicines based on messenger ribonucleic acid. The company's lead clinical programs include CV8102. CureVac B.V. is based in Germany.

See More

Key Turning Points

3rd Resistance Point 14.37
2nd Resistance Point 14.08
1st Resistance Point 13.92
Last Price 13.76
1st Support Level 13.47
2nd Support Level 13.18
3rd Support Level 13.02

See More

52-Week High 75.68
Fibonacci 61.8% 51.50
Fibonacci 50% 44.03
Fibonacci 38.2% 36.57
Last Price 13.76
52-Week Low 12.39

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar